Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 0.05%.

  • Organogenesis Holdings' Return on Invested Capital fell 300.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.02% for FY2024, which is 400.0% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Return on Invested Capital of 0.05% as of Q3 2025, which was down 300.0% from 0.08% recorded in Q2 2025.
  • Organogenesis Holdings' Return on Invested Capital's 5-year high stood at 0.37% during Q4 2021, with a 5-year trough of 0.1% in Q1 2025.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.05% (2023), whereas its average is 0.1%.
  • Per our database at Business Quant, Organogenesis Holdings' Return on Invested Capital soared by 6000bps in 2021 and then tumbled by -3100bps in 2022.
  • Over the past 5 years, Organogenesis Holdings' Return on Invested Capital (Quarter) stood at 0.37% in 2021, then crashed by -83bps to 0.06% in 2022, then crashed by -67bps to 0.02% in 2023, then crashed by -178bps to 0.02% in 2024, then tumbled by -226bps to 0.05% in 2025.
  • Its Return on Invested Capital stands at 0.05% for Q3 2025, versus 0.08% for Q2 2025 and 0.1% for Q1 2025.